Cilta-Cel Shows Real-World Feasibility and Efficacy With Acceptable Safety in R/R Myeloma
Dr Usmani on the Efficacy of Daratumumab Plus VRd in Newly Diagnosed, Transplant-Ineligible Myeloma
Targeted Treatment Provides ORR and PFS Benefit in Pretreated Metastatic Solid Tumors
Dr Badros on the Efficacy of Daratumumab Plus Lenalidomide in Newly Diagnosed Myeloma